Clinical Trial Update: Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Biocad completed a Phase 2 comparative trial evaluating the efficacy and safety of BCD-132 against teriflunomide and placebo in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• AUBAGIO (TERIFLUNOMIDE)
• BCD-132 (BCD-132)

Snippet

Sponsor: Biocad | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED